ClinicalTrials.gg
CompletedNCT07891299VR-CABGUpdated Oct 23, 2026

VR During Chest Tube Removal After CABG

An interventional study of VR Shinecon G04EA Virtual Reality Headset in Coronary Artery Bypass Graft Surgery(CABG) and Postoperative Pain Management, sponsored by Maltepe University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Maltepe University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Dec 2024, registered Oct 2026).
Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

he purpose of this clinical trial is to evaluate whether virtual reality can reduce pain, anxiety, and physiological stress during chest tube removal in adult patients undergoing coronary artery bypass graft (CABG) surgery.

The main questions it aims to answer are:

  • Does virtual reality reduce pain intensity during chest tube removal?
  • Does virtual reality reduce anxiety levels and stabilize vital signs? Researchers will compare patients receiving virtual reality with patients receiving routine care to determine whether virtual reality improves patient comfort during the procedure.

Participants will:

  • Be randomly assigned to a virtual reality group or a control group
  • Have their pain, anxiety, and vital signs measured before the procedure
  • Undergo chest tube removal with or without virtual reality
  • Have their pain, anxiety, and vital signs measured again after the procedure
02

Conditions studied

  • Coronary Artery Bypass Graft Surgery(CABG)
  • Postoperative Pain Management

Keywords

  • Coronary Artery Bypass
  • Surgery
  • Virtual Reality
  • Pain
  • Vital Signs
  • Anxiety
03

In context

Pain

2,450 studies on the registry are indexed under Pain; 945 are open to participants now.

This study's enrollment of 82 is above the median of 70 across 2,101 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Maltepe University is the lead sponsor of 67 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Age between 18 and 65 years

Undergoing coronary artery bypass graft surgery

Presence of chest tube

Conscious and oriented

Able to communicate in Turkish

Voluntarily agrees to participate

Exclusion criteria

Exclusion Criteria:

Chronic pain condition requiring regular analgesic use

Migraine, vertigo, or history of dizziness

Visual impairment preventing VR use

Psychiatric disorders

Undergoing different cardiac surgical procedures

Refusal to participate

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
82 participants (actual)

Study arms

  • Experimental
    Virtual Reality Group

    Patients in the experimental group received a virtual reality intervention using a virtual reality headset during chest tube removal following coronary artery bypass graft surgery, in addition to standard care. The intervention was designed to reduce pain and anxiety associated with chest tube removal.

    Device: VR Shinecon G04EA Virtual Reality Headset

  • No intervention
    Control Group

    Control

Interventions

  • DeviceVR Shinecon G04EA Virtual Reality Headset

    Participants in the experimental group receive a virtual reality intervention using the VR Shinecon G04EA virtual reality headset, which displays immersive nature videos accompanied by audio. The intervention begins 5 minutes before chest tube removal and continues throughout the procedure. The virtual reality headset is used as a non-pharmacological distraction method to reduce pain and anxiety associated with chest tube removal. The intervention is administered in addition to routine postoperative care in the cardiovascular intensive care unit following coronary artery bypass graft surgery.

06

What researchers measure

Primary outcomes

  1. Pain Intensity (VAS)

    Pain intensity is assessed using the Visual Analog Scale (VAS), with scores ranging from 0 to 10. A score of 0 indicates no pain, while a score of 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.

    Time frame: Immediately before and immediately after chest tube removal

Secondary outcomes

  1. Anksiyete - State-Trait Anxiety Inventory (STAI-State)

    Anxiety is assessed using the State Anxiety Inventory (STAI-State). Total scores range from 20 to 80, with higher scores indicating greater levels of state anxiety.

    Time frame: Before chest tube removal (baseline) and immediately after completion of chest tube removal (post-intervention).

07

Study locations

1 site
  • Maltepe University
    Istanbul, 0000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891299
Lead sponsor
Maltepe University
Responsible party
Hatice Erdoğan (Assist Prof., Maltepe University) — Principal investigator
First posted
Oct 23, 2026
Start date
Dec 5, 2024
Primary completion
Jan 5, 2026
Completion
Mar 2, 2026
Last update
Oct 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion